amifostine anhydrous has been researched along with Caries, Dental in 2 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shiboski, CH | 1 |
Hodgson, TA | 1 |
Ship, JA | 1 |
Schiødt, M | 1 |
Rudat, V | 1 |
Meyer, J | 1 |
Momm, F | 1 |
Bendel, M | 1 |
Henke, M | 1 |
Strnad, V | 1 |
Grötz, K | 1 |
Schulte, A | 1 |
1 review available for amifostine anhydrous and Caries, Dental
Article | Year |
---|---|
Management of salivary hypofunction during and after radiotherapy.
Topics: Amifostine; Dental Caries; Humans; Muscarinic Agonists; Pilocarpine; Radiation Injuries; Radiation-P | 2007 |
1 trial available for amifostine anhydrous and Caries, Dental
Article | Year |
---|---|
Protective effect of amifostine on dental health after radiotherapy of the head and neck.
Topics: Adult; Aged; Amifostine; Dental Caries; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; | 2000 |